Combating Drug Resistance in Colorectal Cancer Using Herbal Medicines

Chin J Integr Med. 2021 Jul;27(7):551-560. doi: 10.1007/s11655-020-3425-8. Epub 2020 Aug 1.

Abstract

Colorectal cancer (CRC) is one of the most prevalent and lethal cancer types around the world. Most of the CRC patients are treated with chemotherapeutic drugs alone or combined. However, up to 90% of metastatic cancer patients experience the failure of treatment mostly because of the acquired drug resistance, which can be led to multidrug resistance (MDR). In this study, we reviewed the recent literature which studied potential CRC MDR reversal agents among herbal medicines (HMs). Among abundant HMs, 6 single herbs, Andrographis paniculata, Salvia miltiorrhiza, Hedyotis diffusa, Sophora flavescens, Curcuma longa, Bufo gargarizans, and 2 formulae, Pien Tze Huang and Zhi Zhen Fang, were found to overcome CRC MDR by two or more different mechanisms, which could be a promising candidate in the development of new drugs for adjuvant CRC chemotherapy.

Keywords: colorectal cancer; drug resistance; herbal medicine.

Publication types

  • Review

MeSH terms

  • Colorectal Neoplasms* / drug therapy
  • Drug Resistance, Multiple
  • Drugs, Chinese Herbal* / pharmacology
  • Drugs, Chinese Herbal* / therapeutic use
  • Humans
  • Plants, Medicinal*
  • Salvia miltiorrhiza*

Substances

  • Drugs, Chinese Herbal